

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | type I interferon signaling pathway (GO:0060337) | 5.60181195 |
| 2 | cellular response to type I interferon (GO:0071357) | 5.60181195 |
| 3 | response to type I interferon (GO:0034340) | 5.55473617 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.54439927 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.14202522 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.14202522 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09963399 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.79409773 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.72961507 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.72961507 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.72961507 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.72961507 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.72961507 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.72961507 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.56344728 |
| 16 | response to interferon-alpha (GO:0035455) | 4.55309104 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.49291336 |
| 18 | positive regulation of interferon-alpha production (GO:0032727) | 4.48298345 |
| 19 | cellular response to interferon-alpha (GO:0035457) | 4.39505655 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.38937410 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.33239012 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.32795866 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.30254032 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.16210211 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07555765 |
| 26 | negative regulation of viral genome replication (GO:0045071) | 4.07401442 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.06926650 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.03987487 |
| 29 | detection of other organism (GO:0098543) | 3.99143055 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98372247 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91103845 |
| 32 | response to peptidoglycan (GO:0032494) | 3.90029395 |
| 33 | T cell migration (GO:0072678) | 3.88288922 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.86218375 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.78659221 |
| 36 | response to host immune response (GO:0052572) | 3.69752146 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.69752146 |
| 38 | microglial cell activation (GO:0001774) | 3.66026425 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.59898171 |
| 40 | detection of bacterium (GO:0016045) | 3.58682629 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.50165729 |
| 42 | response to host (GO:0075136) | 3.50165729 |
| 43 | response to host defenses (GO:0052200) | 3.50165729 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.46718667 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46087943 |
| 46 | response to interferon-beta (GO:0035456) | 3.44360535 |
| 47 | negative T cell selection (GO:0043383) | 3.42447185 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42329377 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.40268329 |
| 50 | negative thymic T cell selection (GO:0045060) | 3.38710192 |
| 51 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.35925634 |
| 52 | cellular extravasation (GO:0045123) | 3.35325196 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33997916 |
| 54 | response to interleukin-15 (GO:0070672) | 3.32714341 |
| 55 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.31911701 |
| 56 | detection of biotic stimulus (GO:0009595) | 3.25712987 |
| 57 | macrophage activation (GO:0042116) | 3.23887503 |
| 58 | defense response to virus (GO:0051607) | 3.20806007 |
| 59 | leukocyte aggregation (GO:0070486) | 3.19158198 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.17849495 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17176664 |
| 62 | cellular response to virus (GO:0098586) | 3.15197129 |
| 63 | regulation of RIG-I signaling pathway (GO:0039535) | 3.13614596 |
| 64 | regulation of necroptotic process (GO:0060544) | 3.10510030 |
| 65 | cellular response to exogenous dsRNA (GO:0071360) | 3.08380423 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 3.08033837 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.06990156 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03731175 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01805656 |
| 70 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.00927398 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.99194687 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 2.99169415 |
| 73 | cellular response to interferon-beta (GO:0035458) | 2.99109315 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 2.98018806 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97205918 |
| 76 | regulation of viral genome replication (GO:0045069) | 2.97004071 |
| 77 | defense response to protozoan (GO:0042832) | 2.95960874 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.93641204 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 2.92779967 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.92742798 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92449059 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.91176285 |
| 83 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90918749 |
| 84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89360508 |
| 85 | germinal center formation (GO:0002467) | 2.88968005 |
| 86 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.88518010 |
| 87 | regulation of type 2 immune response (GO:0002828) | 2.87862702 |
| 88 | regulation of interferon-beta production (GO:0032648) | 2.87479319 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86221353 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85991562 |
| 91 | hepatocyte apoptotic process (GO:0097284) | 2.85594680 |
| 92 | B cell mediated immunity (GO:0019724) | 2.84306486 |
| 93 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.83202521 |
| 94 | neutrophil activation (GO:0042119) | 2.81805406 |
| 95 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79271191 |
| 96 | positive regulation of tolerance induction (GO:0002645) | 2.79187016 |
| 97 | neutrophil mediated immunity (GO:0002446) | 2.79108338 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79037123 |
| 99 | positive T cell selection (GO:0043368) | 2.76272052 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 2.75430326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.38978933 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.62339151 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.84746593 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.58926208 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.25298385 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.80006189 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.59250782 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.32936915 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.32665612 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25446672 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20975539 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16828545 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93851882 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91833234 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.62343790 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61618142 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50352415 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.50289511 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47726472 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46294214 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46134558 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33460735 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.24354447 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20684485 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17294354 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.02979232 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99758045 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93714805 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.92786547 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90923269 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77524785 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75975586 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.72762732 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68013350 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66072018 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65879061 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63396981 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54936354 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.52569743 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52421746 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52176950 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50250123 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48216005 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47774919 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42724821 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41630008 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34250024 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33294110 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29591954 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27744657 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24942608 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24684460 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.24093943 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19651331 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18736890 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.18449861 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16309662 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15296071 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13977725 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13786738 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06434406 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06097796 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01258024 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00279109 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99908666 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98343883 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97505287 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97482086 |
| 69 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96061917 |
| 70 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96061917 |
| 71 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94743799 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93976745 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93926221 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92281216 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92233694 |
| 76 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.91328940 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90694136 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90576286 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89796998 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88865319 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88738805 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87538949 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86733227 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84409433 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84314964 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81874683 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80442038 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78737155 |
| 89 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78619682 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77850388 |
| 91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74015405 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73086118 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72898066 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72894011 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72847784 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72565066 |
| 97 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.70095000 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70090583 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67970146 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.67058313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.35511339 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.31903360 |
| 3 | MP0003303_peritoneal_inflammation | 3.56383440 |
| 4 | MP0009785_altered_susceptibility_to | 3.21733946 |
| 5 | MP0003436_decreased_susceptibility_to | 3.17935183 |
| 6 | MP0001800_abnormal_humoral_immune | 2.86729778 |
| 7 | MP0006082_CNS_inflammation | 2.83660488 |
| 8 | MP0005671_abnormal_response_to | 2.79010362 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.75871452 |
| 10 | MP0005025_abnormal_response_to | 2.70278035 |
| 11 | MP0001790_abnormal_immune_system | 2.65135178 |
| 12 | MP0005387_immune_system_phenotype | 2.65135178 |
| 13 | MP0000685_abnormal_immune_system | 2.63868479 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.60791725 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.55269421 |
| 16 | MP0002419_abnormal_innate_immunity | 2.53849965 |
| 17 | MP0002723_abnormal_immune_serum | 2.50843030 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.47854652 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.46373743 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.26141289 |
| 21 | MP0001819_abnormal_immune_cell | 2.25485881 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.16535154 |
| 23 | MP0008260_abnormal_autophagy | 2.05510378 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.01256494 |
| 25 | MP0004947_skin_inflammation | 1.96595523 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.95507864 |
| 27 | MP0005451_abnormal_body_composition | 1.89546153 |
| 28 | MP0002398_abnormal_bone_marrow | 1.81867201 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.80573526 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.79365456 |
| 31 | MP0000716_abnormal_immune_system | 1.78138745 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78047680 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.77776120 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.73831057 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.69849669 |
| 36 | MP0002006_tumorigenesis | 1.67250225 |
| 37 | MP0009764_decreased_sensitivity_to | 1.54899650 |
| 38 | MP0008469_abnormal_protein_level | 1.46434163 |
| 39 | MP0002722_abnormal_immune_system | 1.46106288 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.45657042 |
| 41 | MP0000858_altered_metastatic_potential | 1.44064427 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.42318054 |
| 43 | MP0002429_abnormal_blood_cell | 1.41083872 |
| 44 | MP0004883_abnormal_blood_vessel | 1.40412971 |
| 45 | MP0003866_abnormal_defecation | 1.37692313 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.35435796 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.35048121 |
| 48 | MP0005310_abnormal_salivary_gland | 1.34651026 |
| 49 | MP0005164_abnormal_response_to | 1.34076179 |
| 50 | MP0003828_pulmonary_edema | 1.34034340 |
| 51 | MP0003448_altered_tumor_morphology | 1.30354562 |
| 52 | MP0001853_heart_inflammation | 1.29365148 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.28862168 |
| 54 | MP0004381_abnormal_hair_follicle | 1.28709919 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.24120746 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.24120746 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.24102395 |
| 58 | MP0003091_abnormal_cell_migration | 1.20612052 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.19164079 |
| 60 | MP0003075_altered_response_to | 1.17469031 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.17424264 |
| 62 | MP0003045_fibrosis | 1.14911606 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.14755097 |
| 64 | MP0005166_decreased_susceptibility_to | 1.12938460 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.11570454 |
| 66 | MP0009278_abnormal_bone_marrow | 1.07337181 |
| 67 | MP0001851_eye_inflammation | 1.07151456 |
| 68 | MP0000343_altered_response_to | 1.03686948 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.02700032 |
| 70 | MP0004510_myositis | 1.01348089 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99428418 |
| 72 | MP0003690_abnormal_glial_cell | 0.97686957 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.97319151 |
| 74 | MP0008004_abnormal_stomach_pH | 0.97312942 |
| 75 | MP0009763_increased_sensitivity_to | 0.96673665 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.96333693 |
| 77 | MP0006054_spinal_hemorrhage | 0.94690949 |
| 78 | MP0008057_abnormal_DNA_replication | 0.93324768 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.93183689 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.91255340 |
| 81 | MP0000604_amyloidosis | 0.88020481 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.84970462 |
| 83 | MP0001873_stomach_inflammation | 0.84809072 |
| 84 | MP0002009_preneoplasia | 0.76804667 |
| 85 | MP0002132_abnormal_respiratory_system | 0.76784508 |
| 86 | MP0000249_abnormal_blood_vessel | 0.74513173 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.73242304 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.72663769 |
| 89 | MP0005023_abnormal_wound_healing | 0.70550041 |
| 90 | MP0005390_skeleton_phenotype | 0.69761806 |
| 91 | MP0001663_abnormal_digestive_system | 0.69657433 |
| 92 | MP0001958_emphysema | 0.69194623 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.65975706 |
| 94 | MP0002933_joint_inflammation | 0.65736887 |
| 95 | MP0003795_abnormal_bone_structure | 0.65197379 |
| 96 | MP0000371_diluted_coat_color | 0.64741383 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.64657970 |
| 98 | MP0008874_decreased_physiological_sensi | 0.62564191 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.62416333 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.61848156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.38803658 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.30287314 |
| 3 | T lymphocytopenia (HP:0005403) | 4.90389552 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.89534088 |
| 5 | Optic neuritis (HP:0100653) | 4.76678972 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.76678972 |
| 7 | Orchitis (HP:0100796) | 4.74238496 |
| 8 | Myositis (HP:0100614) | 4.69973022 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.68716033 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.22386376 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.02245685 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.02245685 |
| 13 | Recurrent viral infections (HP:0004429) | 3.97254089 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94870103 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.94003075 |
| 16 | Recurrent skin infections (HP:0001581) | 3.89893572 |
| 17 | Stomatitis (HP:0010280) | 3.77127209 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.74143257 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.68706891 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.63514618 |
| 21 | Vasculitis (HP:0002633) | 3.50928996 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.47851823 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.43985440 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36619452 |
| 25 | Meningitis (HP:0001287) | 3.33418335 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.28006405 |
| 27 | Abnormality of T cells (HP:0002843) | 3.21306833 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.19218580 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.15640008 |
| 30 | Hemoptysis (HP:0002105) | 3.14892779 |
| 31 | Spontaneous hematomas (HP:0007420) | 3.13854164 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.05107210 |
| 33 | Encephalitis (HP:0002383) | 3.04958064 |
| 34 | Arterial thrombosis (HP:0004420) | 2.97086516 |
| 35 | Gingival bleeding (HP:0000225) | 2.96810626 |
| 36 | * Gingivitis (HP:0000230) | 2.86237856 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84392365 |
| 38 | Obstructive lung disease (HP:0006536) | 2.84392365 |
| 39 | Peritonitis (HP:0002586) | 2.84175853 |
| 40 | Urticaria (HP:0001025) | 2.82567310 |
| 41 | Leukocytosis (HP:0001974) | 2.80393724 |
| 42 | Cellulitis (HP:0100658) | 2.72357311 |
| 43 | Increased IgM level (HP:0003496) | 2.68207796 |
| 44 | Chest pain (HP:0100749) | 2.66020503 |
| 45 | Pustule (HP:0200039) | 2.63262839 |
| 46 | Increased IgE level (HP:0003212) | 2.62465049 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.58444334 |
| 48 | Eosinophilia (HP:0001880) | 2.54337668 |
| 49 | Granulocytopenia (HP:0001913) | 2.53181693 |
| 50 | Cheilitis (HP:0100825) | 2.52819130 |
| 51 | Colitis (HP:0002583) | 2.52532325 |
| 52 | Gangrene (HP:0100758) | 2.50801777 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.49332306 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.43570312 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.41372539 |
| 56 | Anorexia (HP:0002039) | 2.34557966 |
| 57 | Epistaxis (HP:0000421) | 2.34441113 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.34020399 |
| 59 | Subacute progressive viral hepatitis (HP:0006572) | 2.32796594 |
| 60 | Osteomyelitis (HP:0002754) | 2.31986471 |
| 61 | Chronic diarrhea (HP:0002028) | 2.28238768 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.25527512 |
| 63 | Pulmonary embolism (HP:0002204) | 2.25342353 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.25151338 |
| 65 | Viral hepatitis (HP:0006562) | 2.23014945 |
| 66 | Skin ulcer (HP:0200042) | 2.16868167 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.16687675 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.16311484 |
| 69 | Interstitial pulmonary disease (HP:0006530) | 2.15630675 |
| 70 | Periodontitis (HP:0000704) | 2.14645059 |
| 71 | Abnormality of the endocardium (HP:0004306) | 2.13170128 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.13107039 |
| 73 | Glomerulopathy (HP:0100820) | 2.12986781 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.11921686 |
| 75 | Abnormality of the peritoneum (HP:0002585) | 2.08958636 |
| 76 | Sepsis (HP:0100806) | 2.07640791 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07200981 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07200981 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07200981 |
| 80 | Fatigue (HP:0012378) | 2.06377901 |
| 81 | B lymphocytopenia (HP:0010976) | 2.04464258 |
| 82 | Chronic otitis media (HP:0000389) | 2.03546422 |
| 83 | Hematochezia (HP:0002573) | 2.02944771 |
| 84 | IgA deficiency (HP:0002720) | 2.02601507 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01669329 |
| 86 | Loss of speech (HP:0002371) | 2.01212581 |
| 87 | IgG deficiency (HP:0004315) | 2.01016348 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.00885019 |
| 89 | Lymphopenia (HP:0001888) | 1.98371336 |
| 90 | Basal ganglia calcification (HP:0002135) | 1.97545469 |
| 91 | Acute hepatic failure (HP:0006554) | 1.96910083 |
| 92 | Keratitis (HP:0000491) | 1.96145823 |
| 93 | Joint swelling (HP:0001386) | 1.96050764 |
| 94 | Episodic fever (HP:0001954) | 1.90682968 |
| 95 | Abnormality of the pericardium (HP:0001697) | 1.87072496 |
| 96 | Thyroiditis (HP:0100646) | 1.86474351 |
| 97 | Amaurosis fugax (HP:0100576) | 1.83405205 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82770358 |
| 99 | Skin rash (HP:0000988) | 1.82195095 |
| 100 | Verrucae (HP:0200043) | 1.82128519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.81487135 |
| 2 | RIPK4 | 3.37548878 |
| 3 | IKBKE | 3.18527908 |
| 4 | BLK | 3.13460943 |
| 5 | JAK3 | 3.06645601 |
| 6 | MAP4K1 | 2.98736431 |
| 7 | JAK1 | 2.90692878 |
| 8 | MAP3K14 | 2.72532975 |
| 9 | IRAK4 | 2.58606098 |
| 10 | FGFR4 | 2.46189855 |
| 11 | PRPF4B | 2.38217932 |
| 12 | CSK | 2.36521467 |
| 13 | TXK | 2.28588676 |
| 14 | FGFR3 | 2.16713373 |
| 15 | BMPR2 | 1.96995434 |
| 16 | MAP2K3 | 1.96304996 |
| 17 | TBK1 | 1.86325648 |
| 18 | KIT | 1.81996044 |
| 19 | ZAP70 | 1.77419295 |
| 20 | BTK | 1.70857068 |
| 21 | MAP3K13 | 1.70162999 |
| 22 | FES | 1.60649174 |
| 23 | SYK | 1.59161190 |
| 24 | FGR | 1.52243706 |
| 25 | ERN1 | 1.50784692 |
| 26 | GRK6 | 1.45721983 |
| 27 | IRAK3 | 1.40821353 |
| 28 | TAOK3 | 1.39324094 |
| 29 | JAK2 | 1.39000728 |
| 30 | MAP3K3 | 1.33811528 |
| 31 | TEC | 1.32853517 |
| 32 | HCK | 1.32106928 |
| 33 | ITK | 1.29901434 |
| 34 | PIK3CG | 1.27504403 |
| 35 | IKBKB | 1.24610650 |
| 36 | GRK7 | 1.22834932 |
| 37 | LYN | 1.21588561 |
| 38 | STK10 | 1.21363123 |
| 39 | IRAK1 | 1.20880776 |
| 40 | EPHB1 | 1.20731312 |
| 41 | LCK | 1.18707633 |
| 42 | RIPK1 | 1.17315262 |
| 43 | MAP3K2 | 1.14178457 |
| 44 | TGFBR2 | 1.11475586 |
| 45 | MATK | 1.06822191 |
| 46 | CAMKK2 | 1.04321909 |
| 47 | CSF1R | 1.00623472 |
| 48 | NEK9 | 0.99697250 |
| 49 | MAP3K1 | 0.98868930 |
| 50 | IRAK2 | 0.89833110 |
| 51 | SIK3 | 0.89311104 |
| 52 | YES1 | 0.87324404 |
| 53 | NLK | 0.87135093 |
| 54 | LRRK2 | 0.84245885 |
| 55 | MARK3 | 0.81242753 |
| 56 | MAPK11 | 0.80308931 |
| 57 | TAOK2 | 0.77052826 |
| 58 | MAP3K6 | 0.75724649 |
| 59 | TAOK1 | 0.73887139 |
| 60 | PIM1 | 0.70327999 |
| 61 | TRPM7 | 0.68521821 |
| 62 | HIPK2 | 0.68231743 |
| 63 | CDC42BPA | 0.64671347 |
| 64 | KSR2 | 0.62993695 |
| 65 | CDK6 | 0.60357551 |
| 66 | TNK2 | 0.60209904 |
| 67 | PDK1 | 0.59935384 |
| 68 | CDK12 | 0.58946602 |
| 69 | MAP3K5 | 0.57417160 |
| 70 | WNK1 | 0.57391783 |
| 71 | CHUK | 0.56117463 |
| 72 | MAPK7 | 0.54958311 |
| 73 | MELK | 0.54721004 |
| 74 | PTK2B | 0.54412867 |
| 75 | MAP3K11 | 0.49299560 |
| 76 | MARK2 | 0.49193258 |
| 77 | MOS | 0.49025367 |
| 78 | PRKCQ | 0.48948497 |
| 79 | STK4 | 0.47486178 |
| 80 | SGK3 | 0.45524847 |
| 81 | MST1R | 0.45362784 |
| 82 | EGFR | 0.42227734 |
| 83 | MAP3K10 | 0.42129027 |
| 84 | ACVR1B | 0.42114935 |
| 85 | PDGFRB | 0.41949587 |
| 86 | STK24 | 0.41916442 |
| 87 | FYN | 0.41680216 |
| 88 | CDK4 | 0.41402229 |
| 89 | KSR1 | 0.40408737 |
| 90 | RAF1 | 0.39090130 |
| 91 | EPHA3 | 0.38315039 |
| 92 | CLK1 | 0.38121850 |
| 93 | PDPK1 | 0.36718491 |
| 94 | SGK2 | 0.33126635 |
| 95 | ABL1 | 0.31895592 |
| 96 | MAPKAPK2 | 0.30918011 |
| 97 | MAP3K12 | 0.28214039 |
| 98 | RET | 0.28109451 |
| 99 | BRD4 | 0.27823692 |
| 100 | MAP2K6 | 0.27026615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81866707 |
| 2 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.56501119 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55816001 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.55684209 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52948879 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.46781540 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41283938 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29868053 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26724158 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23876762 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.21760106 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15135779 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.07100279 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03769148 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00334147 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.95249690 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.95096138 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82743257 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.82052181 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.76887739 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76103717 |
| 22 | Hepatitis C_Homo sapiens_hsa05160 | 1.74640467 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.73014019 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69673569 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67723268 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66293430 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65948939 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65730450 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64041939 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59877245 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.57537388 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.56070034 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44133086 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42836335 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41265018 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38350306 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35495362 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35476476 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26945005 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19964963 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17283679 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.17157915 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16222347 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.11774365 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08437614 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08001388 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04794875 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 1.03375589 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96798678 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95807163 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.95071864 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.93768547 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.93409182 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92178541 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91796818 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88502803 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80726501 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78927866 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76612124 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74682458 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72203563 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71308438 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.69679613 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69324730 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62841870 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62350451 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60287090 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58928492 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.58723137 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58235574 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57889343 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55807192 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54398223 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52242859 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52056779 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51031153 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.50967859 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50499568 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49160757 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.46799519 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44598066 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43905687 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.42550071 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.42193216 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.40921441 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39679678 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39400380 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39336908 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38509582 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38041627 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37939058 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37705339 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36178562 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32040926 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32028275 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31743045 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31131493 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30486977 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30473997 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30049266 |

